UNIVERSITY OF ROCHESTER CANCER CENTER-CCOP RESEARCH BASE

研究机构罗切斯特大学癌症中心（URCC） 在罗切斯特大学医学和牙科学院， 建议继续作为社区临床研究基地 肿瘤学计划（CCOP）申请机构。 原创研究 自1983年以来为CCOP计划服务的基地，URCC/CCOP研究基地 已经发展和开发了相当多的癌症控制资源， 研究活动。 9项CCOP临床试验（5项癌症治疗 和四种癌症控制）已经开发，由NCI批准， 由我们的研究基地的附属机构在当前赠款期间实施 退款 每个国家都登记了50多个癌症控制学分。 过去两年里。 URCC研究基地致力于一个过程和气候， 通过成员CCOP之间的合作促进规程的制定 和附属机构，在我们的研究基地经验丰富的癌症控制专家， 和癌症控制领域的顾问。 这种竞争性的更新集中在 在发展和实施癌症控制方面的优势 作为大学癌症中心癌症控制研究基地进行研究 只. 我们目前提供六种NCI批准的癌症控制方案： 三个是随机干预试验， 生物行为和药物干预， 相关疾病。

The University of Rochester Cancer Center (URCC), a research institute within the University of Rochester School of Medicine and Dentistry, proposes to continue serving as a Research Base for Community Clinical Oncology Program (CCOP) applicant institutions. A original Research Base serving the CCOP program since 1983, the URCC/CCOP Research Base has evolved and developed considerable resources for cancer control research activities. Nine CCOP clinical trials (five cancer treatment and four cancer control) have been developed, approved by NCI and implemented by affliates of our Research Base during the current grant renewal. Over fifty cancer control credits have been registered in each of the past two years. The URCC Research Base is committed to a process and climate that fosters protocol development through collaboration among member CCOPs and affliates, experienced cancer control experts at out Research Base, and consultants in cancer control areas. This competing renewal focuses on strengths in the development and implementation of cancer control studies as a University Cancer Center Research Base for cancer control only. We currently offer six NCI approved cancer control protocols: three are randomized intervention trials that examine the effectiveness of biobehavioral and pharmacologic interventions in reducing treatment related morbidity.